Lyne Gagnon

1.7k citations
52 papers · 1.2k indexed · h-index 19

Lyne Gagnon

51 papers receiving 1.2k citations

Peers

Lyne Gagnon
Comparison fields: 5 of 90
  • Oncology 317
  • Immunology 224
  • Nephrology 69
  • Biochemistry 57
  • Molecular Biology 565
Replace Carl Whatling with:
Carl Whatling Sweden
Emma Folch‐Puy Spain
Hongkun Wu China
Tomonari Koike Japan
I. Ahnfelt‐Rønne Denmark
Jing Hou China
Giulia Matacchione Italy
Chun Wang China
Hervé Lemaréchal France
Fausto Andreola United Kingdom
Lyne Gagnon relative to Carl Whatling Sweden Carl Whatling's profile →
Citations per field
00.5×2.7×
Carl Whatling · 1×
Citations per year

Countries citing papers authored by Lyne Gagnon

Since Specialization
Citations

This map shows the geographic impact of Lyne Gagnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lyne Gagnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lyne Gagnon more than expected).

Fields of papers citing papers by Lyne Gagnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lyne Gagnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lyne Gagnon. The network helps show where Lyne Gagnon may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Lyne Gagnon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Lyne Gagnon Line = papers co-authored together Lyne Gagnon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20220
2 20191
3 201822
4 201884
5 201822
6
Abstract 19469: PBI-4050 Reduces Cardiovascular Biomarkers in Type II Diabetic Patients With Metabolic Syndrome
20162
7 20161
8 20076
9 200131
10 200013
11 20007
12 199861
13 19953
14 19944
15 19948
16 19926
17 1992132
18 198960
19 198827
20 198721

About Lyne Gagnon

Lyne Gagnon is a scholar working on Emergency Medical Services, Immunology and Hematology, having authored 52 papers that have together received 1.2k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (7 papers), Protein Kinase Regulation and GTPase Signaling (5 papers), Pediatric health and respiratory diseases (5 papers), Liver Disease Diagnosis and Treatment (5 papers), Immune Response and Inflammation (4 papers), Synthesis and Characterization of Heterocyclic Compounds (3 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Metabolism, Diabetes, and Cancer (3 papers). The work is most often cited by research in Oncology (317 citations), Immunology (224 citations) and Nephrology (69 citations). Lyne Gagnon has collaborated with scholars based in Canada, United States and Croatia. Frequent co-authors include Marek Rola‐Pleszczynski, Pierré Sirois, Gordon E. Willick, Witold Neugebauer, Balu Chakravarthy, J. F. Whitfield, Hervé Jouishomme, Jon P. Durkin, Susanne MacLean and Boulos Zacharie. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026